<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0500">
 <element-citation publication-type="journal" id="rf0500">
  <person-group person-group-type="author">
   <name>
    <surname>Scharton</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Bailey</surname>
    <given-names>K.W.</given-names>
   </name>
   <name>
    <surname>Vest</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Westover</surname>
    <given-names>J.B.</given-names>
   </name>
   <name>
    <surname>Kumaki</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Van Wettere</surname>
    <given-names>A.</given-names>
   </name>
   <span class="x" xmlns="http://www.w3.org/1999/xhtml">â€¦</span>
   <name>
    <surname>Gowen</surname>
    <given-names>B.B.</given-names>
   </name>
  </person-group>
  <article-title>Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment</article-title>
  <source>
   <italic>Antiviral Research</italic>
  </source>
  <volume>104</volume>
  <year>2014</year>
  <fpage>84</fpage>
  <lpage>92</lpage>
  <pub-id pub-id-type="pmid">24486952</pub-id>
 </element-citation>
</ref>
